熱門資訊> 正文
索诺玛和电磁兼容将共同营销扩大的眼部护理产品线
2024-09-11 21:01
- Sonoma Pharmaceuticals (NASDAQ:SNOA) said on Wednesday it has entered into a co-marketing agreement with EMC Pharma to launch and sell an expanded prescription and OTC eye care product line.
- Sonoma (SNOA) and EMC Pharma entered into a distribution agreement in 2021, granting EMC Pharma the exclusive right to manage, market and distribute Sonoma's HOCl-based prescription dermatology and eye care products in the United States.
- EMC Pharma will now additionally have the right to sell over-the-counter Ocucyn, and Sonoma will have the right to sell Acuicyn eyelid & eyelash cleanser.
More on Sonoma Pharmaceuticals
- Sonoma Pharmaceuticals reports Q1 results
- Seeking Alpha’s Quant Rating on Sonoma Pharmaceuticals
- Historical earnings data for Sonoma Pharmaceuticals
- Financial information for Sonoma Pharmaceuticals
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
